PET/CT of cancer patients

Part 1, pancreatic neoplasms

Elizabeth H. Dibble, Dimitrios Karantanis, Gustavo Mercier, Patrick J. Peller, Lisa A. Kachnic, Rathan M. Subramaniam

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: Pancreatic cancer continues to have a poor prognosis despite impressive improvements in the outcomes of many other types of cancer, often because most pancreatic neoplasms are found to be unresectable at diagnosis. The purpose of this review is to provide an overview of pancreatic cancer and the role of modern imaging in its diagnosis and management with an emphasis on 18F-FDG PET/CT fusion imaging. CONCLUSION: Multimodality imaging is critical in the diagnosis and management of pancreatic cancer. PET/CT is increasingly viewed as a useful, accurate, and cost-effective modality in diagnosing and managing pancreatic cancer, but further studies are warranted. Early data suggest that contrast-enhanced PET/CT performed with modern PET/CT scanners yields high-resolution anatomic information for surgical and radiotherapeutic planning and functional information for whole-body staging in the care of patients with this disease.

Original languageEnglish (US)
Pages (from-to)952-967
Number of pages16
JournalAmerican Journal of Roentgenology
Volume199
Issue number5
DOIs
StatePublished - Nov 2012

Fingerprint

Pancreatic Neoplasms
Neoplasms
Fluorodeoxyglucose F18
Patient Care
Costs and Cost Analysis

Keywords

  • CT
  • MRI
  • Pancreatic cancer
  • PET/CT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Dibble, E. H., Karantanis, D., Mercier, G., Peller, P. J., Kachnic, L. A., & Subramaniam, R. M. (2012). PET/CT of cancer patients: Part 1, pancreatic neoplasms. American Journal of Roentgenology, 199(5), 952-967. https://doi.org/10.2214/AJR.11.8182

PET/CT of cancer patients : Part 1, pancreatic neoplasms. / Dibble, Elizabeth H.; Karantanis, Dimitrios; Mercier, Gustavo; Peller, Patrick J.; Kachnic, Lisa A.; Subramaniam, Rathan M.

In: American Journal of Roentgenology, Vol. 199, No. 5, 11.2012, p. 952-967.

Research output: Contribution to journalArticle

Dibble, EH, Karantanis, D, Mercier, G, Peller, PJ, Kachnic, LA & Subramaniam, RM 2012, 'PET/CT of cancer patients: Part 1, pancreatic neoplasms', American Journal of Roentgenology, vol. 199, no. 5, pp. 952-967. https://doi.org/10.2214/AJR.11.8182
Dibble EH, Karantanis D, Mercier G, Peller PJ, Kachnic LA, Subramaniam RM. PET/CT of cancer patients: Part 1, pancreatic neoplasms. American Journal of Roentgenology. 2012 Nov;199(5):952-967. https://doi.org/10.2214/AJR.11.8182
Dibble, Elizabeth H. ; Karantanis, Dimitrios ; Mercier, Gustavo ; Peller, Patrick J. ; Kachnic, Lisa A. ; Subramaniam, Rathan M. / PET/CT of cancer patients : Part 1, pancreatic neoplasms. In: American Journal of Roentgenology. 2012 ; Vol. 199, No. 5. pp. 952-967.
@article{58dc5676d9864c45a9a86dae4fd71828,
title = "PET/CT of cancer patients: Part 1, pancreatic neoplasms",
abstract = "OBJECTIVE: Pancreatic cancer continues to have a poor prognosis despite impressive improvements in the outcomes of many other types of cancer, often because most pancreatic neoplasms are found to be unresectable at diagnosis. The purpose of this review is to provide an overview of pancreatic cancer and the role of modern imaging in its diagnosis and management with an emphasis on 18F-FDG PET/CT fusion imaging. CONCLUSION: Multimodality imaging is critical in the diagnosis and management of pancreatic cancer. PET/CT is increasingly viewed as a useful, accurate, and cost-effective modality in diagnosing and managing pancreatic cancer, but further studies are warranted. Early data suggest that contrast-enhanced PET/CT performed with modern PET/CT scanners yields high-resolution anatomic information for surgical and radiotherapeutic planning and functional information for whole-body staging in the care of patients with this disease.",
keywords = "CT, MRI, Pancreatic cancer, PET/CT",
author = "Dibble, {Elizabeth H.} and Dimitrios Karantanis and Gustavo Mercier and Peller, {Patrick J.} and Kachnic, {Lisa A.} and Subramaniam, {Rathan M.}",
year = "2012",
month = "11",
doi = "10.2214/AJR.11.8182",
language = "English (US)",
volume = "199",
pages = "952--967",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "5",

}

TY - JOUR

T1 - PET/CT of cancer patients

T2 - Part 1, pancreatic neoplasms

AU - Dibble, Elizabeth H.

AU - Karantanis, Dimitrios

AU - Mercier, Gustavo

AU - Peller, Patrick J.

AU - Kachnic, Lisa A.

AU - Subramaniam, Rathan M.

PY - 2012/11

Y1 - 2012/11

N2 - OBJECTIVE: Pancreatic cancer continues to have a poor prognosis despite impressive improvements in the outcomes of many other types of cancer, often because most pancreatic neoplasms are found to be unresectable at diagnosis. The purpose of this review is to provide an overview of pancreatic cancer and the role of modern imaging in its diagnosis and management with an emphasis on 18F-FDG PET/CT fusion imaging. CONCLUSION: Multimodality imaging is critical in the diagnosis and management of pancreatic cancer. PET/CT is increasingly viewed as a useful, accurate, and cost-effective modality in diagnosing and managing pancreatic cancer, but further studies are warranted. Early data suggest that contrast-enhanced PET/CT performed with modern PET/CT scanners yields high-resolution anatomic information for surgical and radiotherapeutic planning and functional information for whole-body staging in the care of patients with this disease.

AB - OBJECTIVE: Pancreatic cancer continues to have a poor prognosis despite impressive improvements in the outcomes of many other types of cancer, often because most pancreatic neoplasms are found to be unresectable at diagnosis. The purpose of this review is to provide an overview of pancreatic cancer and the role of modern imaging in its diagnosis and management with an emphasis on 18F-FDG PET/CT fusion imaging. CONCLUSION: Multimodality imaging is critical in the diagnosis and management of pancreatic cancer. PET/CT is increasingly viewed as a useful, accurate, and cost-effective modality in diagnosing and managing pancreatic cancer, but further studies are warranted. Early data suggest that contrast-enhanced PET/CT performed with modern PET/CT scanners yields high-resolution anatomic information for surgical and radiotherapeutic planning and functional information for whole-body staging in the care of patients with this disease.

KW - CT

KW - MRI

KW - Pancreatic cancer

KW - PET/CT

UR - http://www.scopus.com/inward/record.url?scp=84868031196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868031196&partnerID=8YFLogxK

U2 - 10.2214/AJR.11.8182

DO - 10.2214/AJR.11.8182

M3 - Article

VL - 199

SP - 952

EP - 967

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 5

ER -